✨ Your Portfolio is fetched and updated from zerodha.
Pharmaceuticals
Market Cap
₹0 Cr.
P/E
0.00

Insufficient data

FAQs on Vivek PharmaChem (India) Ltd. Shareprice

There is not enough historical data for the companies share price.

There is insufficient historical data to gauge this.
Latest PE of Vivek PharmaChem is 0

Growth Table
  • Vivek PharmaChem (India) Ltd.
  • Jagsonpal Pharma
  • Roopa Industries
Balance Sheet
  • Vivek PharmaChem (India) Ltd.
  • Jagsonpal Pharma
  • Roopa Industries
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Vivek PharmaChem (India) Ltd.
  • Jagsonpal Pharma
  • Roopa Industries
Cash Flow
  • Vivek PharmaChem (India) Ltd.
  • Jagsonpal Pharma
  • Roopa Industries
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Vivek PharmaChem (India) Ltd.
  • Jagsonpal Pharma
  • Roopa Industries
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Vivek PharmaChem (India) Ltd. Financials

Vivek PharmaChem balance sheet is weak and might have solvency issues

The debt of Vivek PharmaChem is decreasing.
Latest debt of Vivek PharmaChem is ₹19.01 Crs as of Mar-21.
This is less than Mar-20 when it was ₹37.76 Crs.

The profit is oscillating.
The profit of Vivek PharmaChem is ₹6.88 Crs for Mar 2021, ₹8.32 Crs for Mar 2020 and ₹7.42 Crs for Mar 2019

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vivek PharmaChem latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech